ALBANY- In an effort to curb the prevalence of human papillomavirus (HPV)-related cancers, the New York State Department of Health has released a recommendation encouraging parents and healthcare providers to initiate HPV vaccination at the age of 9. The move is supported by recent research demonstrating the efficacy of early HPV vaccination in significantly reducing the risk of related cancers later in life.
HPV vaccines, introduced in the United States in 2006, have exhibited substantial success in diminishing HPV infections and cervical precancers, as highlighted by the Centers for Disease Control and Prevention (CDC). Cognizant of this progress, New York State is spearheading the “Start at Age 9” campaign, which has garnered support from national cancer and sexual health organizations.
leaders underscore the vaccine’s potential to thwart over 90 percent of cancers linked to HPV, positioning it as a vital preventive measure. Dr. James McDonald, the state health commissioner, said, “Getting the HPV vaccine series is the best protection against preventable cancers caused by HPV infection.”
Addressing concerns regarding the vaccine’s safety and efficacy, Dr. McDonald added, “As a pediatrician for more than three decades, I have great confidence in this vaccine and urge all parents and guardians to talk with their child’s provider about the HPV vaccine and enjoy the peace of mind the protection that the vaccine offers.”
Traditionally recommended for administration around ages 11 to 12, HPV vaccinations can now commence as early as age 9, as stated by the CDC. Research suggests that the vaccine triggers a more robust immune response among preteens and young adolescents, in comparison to their older counterparts.
